abstract |
A Bruton's tyrosine kinase inhibitor is disclosed, in particular to a compound of formula (I) or a pharmaceutically acceptable salt thereof, a preparation method thereof, a pharmaceutical composition containing the compound, and its use in the treatment of Bruton's tyrosine Use in kinase-related diseases. |